References
- Schrecker AW, Hartwell JL. Communications-components of podophyllin. XX. The absolute configuration of podophyllotoxin and related lignans. J Org Chem. 1956;21(3):381–2.
- Bailly C. Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy, Chem Rev. 2012;112:3611–40.
- Zhao Y, Ge CW, Wu ZH, Wang CN, Fang JH, Zhu L. Synthesis and evaluation of aroylthiourea derivatives of 4-β-amino-4′-O-demethyl-4-desoxy-podophyllotoxin as novel topoisomerase II inhibitors. Eur J Med Chem. 2011;46(3):901–6.
- Zhao Y, Wang CN, Wu ZH, Fang JH, Zhu L. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin. Invest New Drugs. 2012;30(1):17–24
- Zhao Y, Wu ZH, Zhang YT, Zhu L. HY-1 induce G2/M cell cycle arrest in human colon cancer cells via ATR-Chk1-Cdc25C and Weel pathways, Cancer Sci. 2013;104(8):1062–6.
- Choi HJ, Fukui M, Zhu BT. Role of cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole. Plos One. 2011;6(8):1–13.
- Dai XJ, Yamasaki KS, Yang LJ, Sayama KJ, Shirakata YJ, Tokumara S, et al. Keratinocyte G2/M growth arrest by 1,25-dihydroxyvitamin D3 is caused by Cdc2 phosphorylation through Wee1 and Myt1 regulation. J Invest Dermatol. 2004;122(6):1356–64.
- Yu LJ, Orlandi L, Wang P, Orr MS, Senderowicz AM, Sausvillei EA, et al. UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase. J Biol Chem. 1998;273(50):33455–64.
- Tanabe K, Ikegami Y, Ishida R, Andoh T. Inhibition of topoisomerase II by antitumor agents bis (2,6-dioxopiperazine) derivatives. Cancer Res. 1991;51(18):4903–7.
- Gordaliza M, Garcia PA, Corral JM, Castro MA, Gomez-Zurita MA. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon. 2004;44(4):441–59.
- Moon DO, Kim MO, Nam TJ, Kim SK, Choi YH, Kim GY. Pectenotoxin-2 induces G2/M phase cell cycle arrest in human breast cancer cells via ATM and Chk1/2-mediated phosphorylation of cdc25C. Oncol Rep. 2010;24(1):271–6.
- Lu XB, Nguyen TA, Donehower LA. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D. Cell Cycle. 2005;4(8):1060–4.
- Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR–Chk1/2–Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma ovcar-3 cells, Carcinogenesis. 2005;26(11):1978–87.
- Park I, Avraham HK. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1. Exp Cell Res. 2006;312(11):1996–2008.